Securities Code: 002099 Securities Abbreviation: Haixiang Pharmaceutical Announcement No.: 2026-040
Zhejiang Haixiang Pharmaceutical Co., Ltd. Announcement on Share Repurchase Plan
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Key Information Highlights
- Basic Information on Repurchase
Zhejiang Haixiang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will use its own funds or funds raised through centralized bidding to repurchase the Company's shares. The total repurchase amount will be no less than RMB 150 million (inclusive) and no more than RMB 300 million (inclusive). The repurchase price will not exceed RMB 8.55 per share (inclusive). Based on the upper limit of the repurchase amount of RMB 300 million and the upper limit of the repurchase price of RMB 8.55 per share, the estimated number of shares to be repurchased is approximately 35.08 million shares, accounting for about 2.17% of the Company's total share capital. The specific repurchase amount and number of shares will be subject to the actual funds used and the number of shares repurchased upon completion of the repurchase. (Hereinafter referred to as the "Current Repurchase")
The implementation period for the repurchase of shares will be within 12 months from the date the Board of Directors approves the share repurchase plan. The repurchased shares will be used for equity incentives or employee stock ownership plans. If the Company fails to use the repurchased shares within 36 months after the completion of the repurchase, the unused repurchased shares will be cancelled. If there are adjustments to national policies, the adjusted policies will apply.
- Plans for Changes in Holdings by Relevant Personnel
During the repurchase period, the Company's directors, senior management, controlling shareholders, actual controllers, and their concerted parties have no definite plans to increase or decrease their holdings of the Company's shares.
- Risk Warnings
(1) There is a risk that the repurchase plan may not be successfully implemented or may only be partially implemented due to reasons such as the Company's stock price continuously exceeding the upper limit disclosed in the repurchase plan during the repurchase period.
(2) There is a risk that the repurchase plan needs to be amended or terminated according to relevant rules due to the occurrence of major events that have a significant impact on the trading price of the Company's shares during the repurchase period.
(3) The repurchased shares are intended for equity incentives or employee stock ownership plans. There is a risk that the repurchased shares may not be granted or may not be fully granted and thus be cancelled due to reasons such as the equity incentive or employee stock ownership plan not being approved by the Company's board of directors, shareholders' meeting, or other decision-making bodies, or the shareholding subjects or incentive subjects waiving their subscription rights.
(4) The funds for this repurchase come from the Company's own funds or raised funds. There is a risk that the funds required for the repurchase may not be available in a timely manner, leading to the repurchase plan not being implemented as planned.
(5) In the event that regulatory authorities issue new repurchase-related normative documents, there is a risk that the implementation process of this repurchase may require adjustments to the corresponding terms based on the new regulatory requirements.
The Company will strive to promote the smooth implementation of this repurchase, and will select opportune moments for repurchase based on market conditions within the repurchase period, and will fulfill its information disclosure obligations in a timely manner based on the progress of the share repurchase. This repurchase will not have a significant impact on the Company's operations, finances, and future development, nor will it affect the Company's listing status. Investors are advised to pay attention to investment risks.